002294.SZ · 信立泰
China A-shares · RS rating 11 · As of 2026-10-14
| Price | 30.43 CNY |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 64 / 28 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 16 / 10 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +55.5% |
| Market cap (USD) | $5.2B |